In vivo maps of extracellular pH in murine melanoma by CEST-MRI

Magnetic Resonance in Medicine

Volumn 71, Issue 1, 2014, Pages 326-332

  Delli Castelli, D ^a   Ferrauto, Giuseppe ^a   Cutrin, Juan Carlos ^a,b   Terreno, Enzo ^a   Aime, Silvio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UBA CONICET   (Argentina)

Author keywords

cancer; CEST agents; MRI; pH map; YbHPDO3A

Indexed keywords

DERMATOLOGY; MAGNETIC RESONANCE IMAGING; ONCOLOGY;

CANCER; CLINICAL TRANSLATION; EXTRACELLULAR PH; EXTRACELLULAR SPACE; SATURATION TRANSFER; SELECTIVE IRRADIATION; SPATIO-TEMPORAL RESOLUTION; YBHPDO3A;

TUMORS;

HPDO3A YB; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CANCER STAGING; CELL HETEROGENEITY; CELL PH; CHEMICAL EXCHANGE SATURATION TRANSFER MAGNETIC RESONANCE IMAGING; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; IRRADIATION; KIDNEY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR GROWTH; URINARY EXCRETION; URINE;

CANCER; CEST AGENTS; MRI; PH MAP; YBHPDO3A;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; EXTRACELLULAR FLUID; HETEROCYCLIC COMPOUNDS, 1-RING; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MICE; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YTTERBIUM;

EID: 84890788605     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24664     Document Type: Article

References (40)

1. Rofstad EK, Mathienses B, Kindem K, Galappathi K,. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006; 66: 6699.
2. Bartkowiak K, Riethdorf S, Pante K,. The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis. Cancer Microenviron 2012; 5: 59-72.
3. Vaupel P, Kallinowski F, Okunieff P,. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-6465.
4. Hjelmeland AB, QWu JM, Heddleston GS, et al. Acidic stress promotes a glioma stem cell phenotype. Cell Death Dis 2011; 18: 829-840.
5. Pouysségur J, Dayan F, Mazure NM,. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006; 441: 437-44.
6. Valliant JF,. Bridge not too far: linking disciplines through molecular imaging probes. J Nucl Med 2010; 51: 1258-1268.
7. Gillies RJ,. pH imaging. A review of pH measurements methods and applications in cancers. IEEE Eng Med Biol Mag 2004; 23: 57-64.
8. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PCM,. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003; 9: 1085-1090.
9. Ward KM, Balaban RS,. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 2000; 44: 799-802.
10. De Leon-Rodriguez LM, Lubag AJ, Malloy CR, Martinez GV, Gillies RJ, Sherry AD,. Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res 2009; 42: 948.
11. Terreno E, Delli Castelli D, Aime S,. Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. CMMI 2010; 5: 78-98.
12. Sheth VR, Li YG, Chen LQ, Howison CM, Flask CA, Pagel MD,. Measuring in vivo tumor pHe with CEST-FISP MRI. Magn Reson Med 2012; 67: 760-768.
13. Longo D, Terreno E, Aime S,. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: in vivo studies in mice at 7 T. Magn Reson Med 2011; 65: 202-211.
14. Wu YK, Soesbe TC, Kiefer GE, Zhao PY, Sherry AD,. A responsive europium(III) chelate that provides a direct redout of pH by MRI. J Am Chem Soc 2012; 132: 4002-4003.
15. Aime S, Barge A, Delli Castelli D, Fedeli F, Mortillaro A, Nielsen FU, Terreno E,. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 2002; 47; 639-648.
16. Terreno E, Delli Castelli D, Cravotto G, Milone L, Aime S,. Ln(III)-DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications. Invest Radiol 2004; 39: 235-243.
17. Delli Castelli D, Terreno E, Aime S,. Yb(III)-HPDO3A: a dual pH- and temperature responsive CEST agent. Angew Chem Int Ed Engl 2011; 50: 1798-1800.
18. Smith W,. Responses of laboratory animals to some injectable anesthetics. Lab Anim, 1993; 27: 30-39.
19. Flecknell PA,. Laboratory animal anesthesia. London: Academic Press Limited; 1996. p 159.
20. Suckow MA, Danneman P, Brayton C,. The laboratory mouse. CRC Press, Boca Raton, London, New York, Washington, D.C; 2001. p 183.
21. Fish R, Danneman PJ, Brown M, Karas A,. Anesthesia and analgesia in laboratory animals, 2nd ed. American College of Laboratory Animal Medicine. Animal medicine series; 1997. P629.
22. Erhardt W, Hebestedt A, Aschenbrenner G, Pichotka B, Blümel G,. A comparative study with various anesthetics in mice. Res Exp Med (Berl) 1984; 184: 159-169.
23. Scott DA, Richardson AD, Filipp FV, Knutzen CA, Chiang GG, Ronai ZA, Osterman AL, Smith JW,. Comparative metabolic flux profiling of melanoma cell lines: beyond the warburg effect. Cancer Res 2011; 286: 42626-42634.
24. Gray-Schopfer V, Wellbrock C, Marais R,. Melanoma biology and new targeted therapy. Nature 2007; 445: 851-857.
25. Bayley IP, Devilee P,. The Warburg effect in 2012. Curr Opin Oncol 2012; 24: 62-67.
26. Vaupel P, Kallinowski F, Okunieff P,. Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Rev 1989; 49: 6449-6465.
27. Warburg O,. The metabolism of tumors. London: Arnold Constable; 1930.
28. Brahimi-Horn MC, Bellot G, Pouyssègur J,. Hypoxia and energetic tumor metabolism. Curr Opin Genet Dev 2011; 21: 67-72.
29. Chiche J, Brahimi-Horn MC, Pouyssègur J,. Tumor hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 2009; 14: 771-794.
30. Gillies RJ, Robey I, Gatenby RA,. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 2008; 49: 24S-42S.
31. Gatenby RA, Gillies RJ, Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
32. Martinez-Outschoorn UE, Pestell RG, Howell A, Tykocinski ML, Nagajyothi F, Machado FS, Tanowitz HB, Sotgia F, Lisanti MP,. Energy transfer in "parasitic" cancer metabolism. Cell Cycle 2011; 10: 4208-16.
33. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, et al. Evidence for a stromal- epithelial "lactate shuttle" in human tumors. MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011; 10: 1772-1783.
34. Neri D, Supuran CT,. Interfering with pH regulation in tumors as a therapeutic strategy. Rev Nat Rev Drug Discov 2011; 10: 767-777.
35. Robey IF, Baggett BK, Kirkpatrick ND, et al. Bicarbonate increase tumor pH and inhibits spontaneous metastases. Cancer Res 2009; 69: 2260-2268.
36. Barge A, Cravotto G, Gianolio E, Fedeli F,. How to determine free Gd and free ligand in solution of Gd chelates. A technical note. CMMI 2006; 1: 184-188.
37. Stancanello J, Terreno E, Castelli DD, Cabella C, Uggeri F, Aime S,. Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. CMMI 2008; 4: 136-149.
38. Terreno E, Stancanello J, Longo D, Castelli DD, Milone L, Sanders HM, Kok MB, Uggeri F, Aime S,. Methods for an improved detection of the MRI-CEST effect. CMMI 2009; 4: 237-247.
39. Gillies RJ, Bhujwalla ZM, Evelhoch J, Garwood M, Neeman M, Robinson SP, Sotak CH, Van Der Sanden B,. Application of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2000; 2: 139-151.
40. Wike-Hooley JL, Haveman J, Reinhold HS,. The relevance of tumor pH to the treatment of malignant disease. Radiother Oncol 1984; 2: 343-366.